Grant: Catalyst Grant: Analysis of CLSA Data
University of Toronto
$70,000.00
Use (or misuse?) of GLP-1 medications in older adults with diabetes: Examining CLSA linked health administrative data
EF 2025-26
Résumé
Medications called GLP-1 receptor agonists (GLP-1 RAs) have changed how we treat type 2 diabetes. These drugs help lower blood sugar and support weight loss, and they've been shown to improve heart health. However, we know very little about how these medications affect older adults; especially how they affect physical function, falls, and injuries. Most large studies on GLP-1 RAs included very few people over age 75, and often excluded those with multiple health problems or physical limitations. This leaves important gaps in our understanding of how these medications work in the real-world. In older adults, physical function (e.g., strength, balance, and mobility) is closely related to independence, quality of life, and risk of hospitalization. Some early research suggests GLP-1 RAs may lead to muscle loss, which could be harmful for older people who may already be at risk of frailty. In Canada, nearly 1 in 5 adults over 65 has diabetes, and the numbers are rising. Despite this, GLP-1 RAs are being prescribed to older adults without strong real-world evidence about their safety or benefits in this age group. Our study will use data from the Canadian Longitudinal Study on Aging (CLSA), linked with Ontario health records, to explore how GLP-1 RAs are being used by older adults and whether they affect physical function, falls, and fractures. We'll look at measures like grip strength, walking speed, and daily activity, as well as emergency visits and hospitalizations. This research will help fill a critical knowledge gap to guide doctors, patients, and policymakers in making informed decisions about diabetes care for Canada's aging population.
Programme
Catalyst Grant: Analysis of CLSA Data
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
536585
Name
Banack Hailey R
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Clinical
Prcname2
Catalyst Grant: Analysis of CLSA Data
Projecttitle
Use (or misuse?) of GLP-1 medications in older adults with diabetes: Examining CLSA linked health administrative data
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$70,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Analysis of CLSA Data
Keyworddelim
Aging; Diabetes; Glp-1ra; Medication; Obesity; Pharmacoepidemiology; Physical Function
Abstract
Medications called GLP-1 receptor agonists (GLP-1 RAs) have changed how we treat type 2 diabetes. These drugs help lower blood sugar and support weight loss, and they've been shown to improve heart health. However, we know very little about how these medications affect older adults; especially how they affect physical function, falls, and injuries. Most large studies on GLP-1 RAs included very few people over age 75, and often excluded those with multiple health problems or physical limitations. This leaves important gaps in our understanding of how these medications work in the real-world. In older adults, physical function (e.g., strength, balance, and mobility) is closely related to independence, quality of life, and risk of hospitalization. Some early research suggests GLP-1 RAs may lead to muscle loss, which could be harmful for older people who may already be at risk of frailty. In Canada, nearly 1 in 5 adults over 65 has diabetes, and the numbers are rising. Despite this, GLP-1 RAs are being prescribed to older adults without strong real-world evidence about their safety or benefits in this age group. Our study will use data from the Canadian Longitudinal Study on Aging (CLSA), linked with Ontario health records, to explore how GLP-1 RAs are being used by older adults and whether they affect physical function, falls, and fractures. We'll look at measures like grip strength, walking speed, and daily activity, as well as emergency visits and hospitalizations. This research will help fill a critical knowledge gap to guide doctors, patients, and policymakers in making informed decisions about diabetes care for Canada's aging population.
Competitiondate
202510
Approvedterm2
1 yr 0 mth
Pinamesdelim
Banack, Hailey R
Approvedterm
1 an 0 mois
Cihrcontribution2
INMD~ $70,000~ $0~